Using of questionnaire of European Society of Cardiology to identify non-conventional risk factors in patients with coronary artery disease in the Kyrgyz Republic

Aim. To analyze the results of using of the European Society of Cardiology (ESC) questionnaire regarding the assessment of non-conventional risk factors in patients with coronary artery disease (CAD).

Material and methods. Three hundred and ten patients with CAD (mean age 59,6±8,8 years, men 62,2) underwent a general clinical examination with the identification of conventional risk factors and assessing standard treatment goals. The cardiologist performed a two-stage assessment of non-conventional risk factors using the ESC questionnaire and validated questionnaires (DS-14, Hamilton Rating Scale for Depression and Anxiety) for clinical identification of anxiety, depression, type D personality.

Results. In hospitalized patients, predominantly we noted severe clinical manifestations of the disease: acute coronary syndrome (51,6%), a decrease in the ejection fraction of less than 50% (40%), a history of acute myocardial infarction (29%), and a high frequency of conventional risk factors: arterial hypertension (75,8%), dyslipidemia (75,1%), obesity (40,9%). The majority of respondents did not reach the standard treatment goals: 13,8% of patients smoked, 30,9% did not follow the lipid-lowering diet, 81,3% did not follow recommendations regarding fish eating, 51,6% did not have recommended physical activity, 40,6% did not reached the target level of blood pressure, 59,3% — the target level of low-density lipoproteins, 59,8% — the target level of body mass index. We determined prevalence of following non-conventional risk factors: hostility (30,9%), type D personality (25,4%), low socio-economic status (12,2%) and anxiety (10%). Depression (5,1%), stress at work and in family life (4,5%), social exclusion (1,6%) were less common.

Conclusion. The results are consistent with data obtained by foreign researchers. The use of the ESC questionnaire allows practitioners to focus on identifying nonconventional risk factors, receive data on the individual risk profile and expand the range of treatment and prevention strategies.

1. Moran АЕ, Forouzanfar MH, Roth GA, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129:1483-92. doi:10.1161/CIRCULATIONAHA.113.004046.

2. World Health Organization. Global status report on non — communicable diseases. http://apps.who.int/iris/bitstream/10665/44579/1/9789240686458_eng.pdf. (20 June 2018).

3. National statistical Committee of the Kyrgyz Republic. Rakhmanova Zh. Zh. public Health and health care in the Kyrgyz Republic 2010-2014. Statistical compendium. Bishkek, 2015 g. (In Russ.) http://www.stat.kg/media/publicationarchive/51acb5e6-fb90-44a2-a2f7-61fc32bb946f.pdf (29 июня 2018).

4. Albus C. Psychosocial risk factors: Time for action in the lifelong prevention of coronary heart disease. Eur J Prev Cardiol. 2017;24(13):1369-70. doi:10.1177/2047487317715770.

5. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010;17:530-40. doi:101097/HJR.0b013e3283383f30.

6. Clark A, King-Shier K, Duncan A, et al. Factors influencing referral to cardiac rehabilitation and secondary prevention programs: a systematic review. Eur J Prev Cardiol. 2012;20:692-700. doi:10.1177/0269215513481046.

7. Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23:636-48. doi:10.1177/2047487315569401.

8. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). European Heart Journal. 2016;37(29):2315-81. doi:101093/eurheartj/ehw106.

9. Pogosova NV, Saner SS, Pedersen ME, et al. Psychosocial aspects in cardiac rehabilitation: from theory to practice. Consensus document of European Association on Cardiovascular Prevention and Rehabilitation Section European Society of Cardiology. Kardiologiia. 2015;10:96-108. (In Russ.) doi:10.18565/cardio.2015.10.96-108.

10. Solozhenkin VV. Elected lectures on psychiatry for cardiologists. Bishkek: Izdatel'stvo Kyrgyzsko-Rossijskogo Slavyanskogo universiteta, 2011. p. 135. (In Russ.) ISBN 978-9967-05-704-3.

11. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European Heart Journal. 2012;33:1635-701. doi:10.1093/eurheartj/ehs092.

12. van Montfort E, Denollet J, Vermunt JK, et al. The tense, the hostile and the distressed: multidimensional psychosocial risk profiles based on the ESC interview in coronary artery disease patients — the THORESCI study. Gen Hosp Psychiatry. 2017;47:103-11. doi:10.1016/j.genhosppsych.2017.05.006.

13. Dennolet J. DS-14: Standart Assessment of Negative Affectivity, Social inhibition and Type D Personality. Psychosomatic Medicine. 2005;67:89-97. doi: 101097/01.psy.0000149256.81953.49.

14. van Montfort E, Denollet J, Widdershoven J, et al. Validity of the European Society of Cardiology's Psychosocial Screening Interview in Patients with Coronary Artery Disease — The THORESCI Study. Psychosom Med. 2017;79(4):404-15. doi:101097/PSY.0000000000000433.